| Secondary |
| Asthma |
40.6% |
| Pain |
11.9% |
| Osteoarthritis |
9.9% |
| Chronic Obstructive Pulmonary Disease |
5.0% |
| Bone Density Decreased |
4.0% |
| Bronchitis |
4.0% |
| Hypertension |
4.0% |
| Acute Myeloid Leukaemia |
3.0% |
| Body Temperature Increased |
3.0% |
| Arthritis |
2.0% |
| Essential Tremor |
2.0% |
| Hiv Infection |
2.0% |
| Infection Prophylaxis |
2.0% |
| Antifungal Prophylaxis |
1.0% |
| Atrial Fibrillation |
1.0% |
| Bronchopulmonary Aspergillosis |
1.0% |
| Cardiac Failure |
1.0% |
| Colitis |
1.0% |
| Disseminated Intravascular Coagulation |
1.0% |
| Leukocytosis |
1.0% |
|
| Osteonecrosis |
19.0% |
| Hypoventilation |
9.5% |
| Malaise |
9.5% |
| Persecutory Delusion |
9.5% |
| Systemic Lupus Erythematosus |
9.5% |
| Asthma |
4.8% |
| Condition Aggravated |
4.8% |
| Fatigue |
4.8% |
| Hyponatraemia |
4.8% |
| Lymphopenia |
4.8% |
| Mesothelioma |
4.8% |
| Synovitis |
4.8% |
| Venous Thrombosis Limb |
4.8% |
| White Blood Cell Count Decreased |
4.8% |
|
| Concomitant |
| Asthma |
58.5% |
| Hypertension |
7.2% |
| Type 2 Diabetes Mellitus |
3.4% |
| Rheumatoid Arthritis |
3.0% |
| Osteoporosis |
2.8% |
| Diabetes Mellitus |
2.6% |
| Pain |
2.6% |
| Hypersensitivity |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Depression |
2.0% |
| Bronchitis Chronic |
1.8% |
| Hypercholesterolaemia |
1.8% |
| Product Used For Unknown Indication |
1.8% |
| Prophylaxis |
1.6% |
| Back Pain |
1.2% |
| Bronchitis |
1.2% |
| Rash |
1.2% |
| Asthma Exercise Induced |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Rhinitis |
1.0% |
|
| Allergic Granulomatous Angiitis |
22.8% |
| Suicidal Ideation |
13.9% |
| Weight Decreased |
6.3% |
| Pancreatic Carcinoma |
5.1% |
| Urinary Tract Infection |
5.1% |
| Asthma |
3.8% |
| Eczema |
3.8% |
| Eosinophilic Myocarditis |
3.8% |
| Gastrooesophageal Reflux Disease |
3.8% |
| Hypotonia |
3.8% |
| Neutropenia |
3.8% |
| Pyelonephritis |
3.8% |
| Abdominal Distension |
2.5% |
| Chest Pain |
2.5% |
| Choroiditis |
2.5% |
| Depression Suicidal |
2.5% |
| Drug Exposure During Pregnancy |
2.5% |
| Dyspnoea |
2.5% |
| Hiccups |
2.5% |
| Hypoglycaemia |
2.5% |
|
| Interacting |
| Asthma |
21.4% |
| Hypertension |
21.4% |
| Coronary Artery Disease |
14.3% |
| Osteoporosis |
14.3% |
| Cardiovascular Disorder |
7.1% |
| Muscle Spasms |
7.1% |
| Secondary Hyperthyroidism |
7.1% |
| Sleep Disorder |
7.1% |
|
|
